secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2026-05-13T20:45:41+00:00
Accession:  0001731122-26-000718
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve reverse stock split at ratio of 1-for-3 to 1-for-30
------------------------------------------------------------------------

- Proposal 1 (reverse split) approved: 13,571,288 for, 1,153,415 against, 61,177 abstentions.
- Proposal 2 (adjournment) approved: 13,626,029 for, 1,091,528 against, 68,323 abstentions.
- Exact split ratio between 1:3 and 1:30 to be set by Board; intended to regain Nasdaq bid price compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000718/0001731122-26-000718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000718/e7639_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer